Injection · 0.25 mg–0.5 mg
Semaglutide Injection 0.25 mg–0.5 mg
Starter-strength semaglutide pens used to begin weekly GLP-1 therapy before stepping up the dose.
Prescription-status medicine in many countries. Use only with a clinician’s advice.
Select pack size
- Tracked delivery included
- 6 to 15 business days
- US · UK · AU · NZ
This pen presentation covers the usual introductory semaglutide doses of 0.25 mg and 0.5 mg. Clinicians often start at 0.25 mg weekly so the gut can adapt, then increase to 0.5 mg.
It is a GLP-1 receptor agonist used, when prescribed, in type 2 diabetes and in some licensed weight-management plans. Do not skip the titration steps your prescriber set.
Global Medica Store ships pens with tracked post. Storage usually requires refrigeration before first use — follow the leaflet.
Key points
- 0.25 mg and 0.5 mg titration strengths
- Weekly injectable GLP-1
- Pen presentation
- Common first step before 1 mg
- Ships to USA, UK, AU and NZ
How it works
After injection, semaglutide binds GLP-1 receptors. When blood glucose is high it can increase insulin secretion and lower glucagon. It also slows gastric emptying and can reduce hunger, which is why many patients notice smaller portions. Response varies, and hypoglycaemia risk rises if it is combined with insulin or sulfonylureas.
Use only as your prescriber directs. Licensed weekly pens are typically started at a low dose and increased slowly to limit nausea. Inject into the abdomen, thigh or upper arm, rotating sites. Do not share pens or vials. Store according to the leaflet — many presentations need refrigeration before first use.
Not for type 1 diabetes or diabetic ketoacidosis. People with a personal or family history of medullary thyroid carcinoma or MEN2 are usually advised to avoid GLP-1 agonists. Common effects include nausea, vomiting, diarrhoea, constipation and reduced appetite. Seek urgent care for severe abdominal pain (possible pancreatitis), signs of a serious allergic reaction, or trouble swallowing. This medicine is prescription-only in many countries.
| Active ingredient | Semaglutide |
|---|---|
| Strength | 0.25 mg–0.5 mg |
| Form | Pre-filled pen |
| Packaging | Pen |
| Typical delivery | 6–15 business days |
| Ships to | Tracked international delivery |
What is semaglutide injection used for?
It is prescribed for type 2 diabetes and, with certain licensed products, for chronic weight management in eligible adults. Your clinician decides whether it is appropriate.
How is the 2 mg injection taken?
Follow the product leaflet and your prescriber. Many branded weekly injections are given subcutaneously once a week on the same day. Do not change the dose yourself.
Can I buy semaglutide injection for international delivery?
Import rules and prescription requirements still apply. Confirm legality and clinical suitability with a local pharmacist or doctor before ordering.
Does it replace a healthy diet?
No. Guidelines pair GLP-1 therapy with nutrition, activity and regular monitoring. Stopping lifestyle measures usually weakens results.
What side effects are most common?
Stomach symptoms — nausea, vomiting, diarrhoea or constipation — especially during dose increases. Report severe or persistent symptoms to a clinician.
Related presentations
Read before you order
Semaglutide Semaglutide pen 0.25–0.5 mg: what it is
The starter weekly pen. Why those milligrams exist, why they are not a maintenance dose, and what to check before you order pens.
Semaglutide How weekly semaglutide injections work
A plain-English look at GLP-1 weekly shots, why titration is used, and what to discuss with a clinician before you order a pen or vial.
Semaglutide Semaglutide injection strengths: 0.25 mg to 4 mg
How starter pens differ from 1 mg, 2 mg and 4 mg weekly injections, and why the milligram on the label should match a clinician’s plan — not a guess.